TGF‐β induces SOX2 expression in a time‐dependent manner in human melanoma cells

The sry‐related high‐mobility box (SOX)‐2 protein has recently been proven to play a significant role in progression, metastasis, and clinical prognosis spanning several cancer types. Research on the role of SOX2 in melanoma is limited and currently little is known about the mechanistic function of this gene in this context. Here, we observed high expression of SOX2 in both human melanoma cell lines and primary melanomas in contrast to melanocytic nevi. This overexpression in melanoma can, in part, be explained by extra gene copy numbers of SOX2 in primary samples. Interestingly, we were able to induce SOX2 expression, mediated by SOX4, via TGF‐β1 stimulation in a time‐dependent manner. Moreover, the knockdown of SOX2 impaired TGF‐β‐induced invasiveness. This phenotype switch can be explained by SOX2‐mediated cross talk between TGF‐β and non‐canonical Wnt signaling. Thus, we propose that SOX2 is involved in the critical TGF‐β signaling pathway, which has been shown to correlate with melanoma aggressiveness and metastasis. In conclusion, we have identified a novel downstream factor of TGF‐β signaling in melanoma, which may have further implications in the clinic.

[1]  A. Weeraratna,et al.  The Wnts of change: How Wnts regulate phenotype switching in melanoma. , 2015, Biochimica et biophysica acta.

[2]  J. Utikal,et al.  SOX2 and cancer: current research and its implications in the clinic , 2014, Clinical and Translational Medicine.

[3]  Yan Wang,et al.  SOX2 promotes the migration and invasion of laryngeal cancer cells by induction of MMP-2 via the PI3K/Akt/mTOR pathway. , 2014, Oncology reports.

[4]  Yi Luo,et al.  RETRACTED ARTICLE: SOX2 oncogenes amplified and operate to activate AKT signaling in gastric cancer and predict immunotherapy responsiveness , 2014, Journal of Cancer Research and Clinical Oncology.

[5]  J. Lachuer,et al.  A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. , 2013, Cancer cell.

[6]  U. Schüller,et al.  Sox2 requirement in sonic hedgehog-associated medulloblastoma. , 2013, Cancer research.

[7]  Yun Lu,et al.  Sox2 cooperates with inflammation-mediated Stat3 activation in the malignant transformation of foregut basal progenitor cells. , 2013, Cell stem cell.

[8]  J. Utikal,et al.  Mediators of induced pluripotency and their role in cancer cells – current scientific knowledge and future perspectives , 2012, Biotechnology journal.

[9]  Adam A. Margolin,et al.  The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.

[10]  M. Mihm,et al.  SOX2 contributes to melanoma cell invasion , 2012, Laboratory Investigation.

[11]  Q. Zhan,et al.  SOX2 and nestin expression in human melanoma: an immunohistochemical and experimental study , 2011, Experimental dermatology.

[12]  F. Lyko,et al.  Demethylation of a LINE-1 antisense promoter in the cMet locus impairs Met signalling through induction of illegitimate transcription , 2010, Oncogene.

[13]  J. Fuxe,et al.  Transcriptional crosstalk between TGFβ and stem cell pathways in tumor cell invasion: Role of EMT promoting Smad complexes , 2010, Cell cycle.

[14]  E. Velazquez,et al.  Expression of the embryonic stem cell transcription factor SOX2 in human skin: relevance to melanocyte and merkel cell biology. , 2010, The American journal of pathology.

[15]  K. Miyazono,et al.  Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. , 2009, Cell stem cell.

[16]  J. Utikal,et al.  Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells , 2009, Journal of Cell Science.

[17]  Yinshi Guo,et al.  Inhibition of PAX3 by TGF-beta modulates melanocyte viability. , 2008, Molecular cell.

[18]  A. Mauviel,et al.  Transforming growth factor‐β in cutaneous melanoma , 2008, Pigment cell & melanoma research.

[19]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[20]  S. Byers,et al.  The role of TGF-β and Wnt signaling in gastrointestinal stem cells and cancer , 2005, Oncogene.

[21]  D. Ambrosetti,et al.  Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation , 2005, The Journal of cell biology.

[22]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[23]  M. Bittner,et al.  Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. , 2002, Cancer cell.

[24]  Jianping Li,et al.  Diagnostic utility of neural stem and progenitor cell markers nestin and SOX2 in distinguishing nodal melanocytic nevi from metastatic melanomas , 2013, Modern Pathology.

[25]  S. Byers,et al.  The role of TGF-beta and Wnt signaling in gastrointestinal stem cells and cancer. , 2005, Oncogene.